Medtronic Stands Behind Proprietary Nature Of AneuRx Clinical Data
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed's intent to craft a position on the release of proprietary data generated by manufacturers during clinical trials should gain momentum from recently publicized study data on Medtronic's AneuRx device
You may also be interested in...
Medical Journals To Require Registration Of Devices On ClinicalTrials.Gov
Medical device firms as well as pharmaceutical companies will be required to register their clinical trials in a public registry as a prerequisite of journal publication, according to New England Journal of Medicine Executive Editor Gregory Curfman, MD
Medical Journals To Require Registration Of Devices On ClinicalTrials.Gov
Medical device firms as well as pharmaceutical companies will be required to register their clinical trials in a public registry as a prerequisite of journal publication, according to New England Journal of Medicine Executive Editor Gregory Curfman, MD
Medtronic AAA stent grafts
Xcelerant delivery system earns CE mark for use with Talent abdominal aortic aneurysm stent graft. The system features improved catheter material and an integrated deployment handle to enhance trackability, aid kink resistance and decrease deployment force, resulting in reduced implant procedure times, Medtronic says. The company also launches "higher density" Resilient graft material for its U.S. AAA stent graft, the AneuRx. The material aims to "reduce porosity and improve durability," the firm explains July 14. Medtronic's AAA announcements follow controversy over an FDA-authored article about AneuRx safety data that was retracted from a peer-review journal after Medtronic threatened litigation over use of proprietary clinical data (1"The Gray Sheet" July 12, 2004, p. 29)...